Who owns the ERBITUX CETUXIMAB trademark?

The ERBITUX CETUXIMAB trademark is owned by ImClone Systems Incorporated.

What class is the ERBITUX CETUXIMAB trademark registered in?

The ERBITUX CETUXIMAB trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ERBITUX CETUXIMAB?

The USPTO serial number for ERBITUX CETUXIMAB is 76463019.

What is the registration number for ERBITUX CETUXIMAB?

ERBITUX CETUXIMAB is registered under USPTO registration number 3392234.

ERB

USPTO Trademark Record

ABANDONED

ERBITUX CETUXIMAB

SN 76463019·Reg 3392234·Filed Sep 10, 2002

Owner ImClone Systems Incorporated

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ERBITUX CETUXIMAB (Serial No. 76463019), Registration No. 3392234, is a abandoned US trademark filed on Sep 10, 2002 by ImClone Systems Incorporated. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

ERBITUX CETUXIMAB (Reg. #3392234) is an abandoned US trademark that was filed in 2002 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Sep 10, 2002

SERIAL

76463019

REG#

3392234

REGISTERED

Mar 04, 2008

Owner

Applicant

ImClone Systems Incorporated

Entity

Corporation

State

Address

180 Varick Street, 6th Floor, New York, NY, 10014

Country

Attorney

NameRobert E. Lee, Jr.

Law firm

Robert E. Lee, Jr. Eli Lilly and Company

Address

Lilly Corporate Center, Indianapolis, IN 46285, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateSep 10, 2002

Serial Number76463019

Registration No.3392234

Registration DateMar 04, 2008

Status DateOct 10, 2014

Published for OppositionApr 29, 2003

Mark TypeDesign with words

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2002

YEARS AGO

24y

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Feb 19, 2004

First use in commerce: Feb 19, 2004

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

34 events

CANCELLED SEC. 8 (6-YR)

Oct 10, 2014

CANCELLED SEC. 8 (6-YR)

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jun 03, 2009

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jun 03, 2009

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Feb 04, 2009

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 21, 2008

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Mar 04, 2008

REGISTERED-PRINCIPAL REGISTER

LAW OFFICE REGISTRATION REVIEW COMPLETED

Jan 28, 2008

LAW OFFICE REGISTRATION REVIEW COMPLETED

EXAMINERS AMENDMENT MAILED

Jan 25, 2008

EXAMINERS AMENDMENT MAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 25, 2008

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

SU-EXAMINER'S AMENDMENT WRITTEN

Jan 24, 2008

SU-EXAMINER'S AMENDMENT WRITTEN

EXAMINER'S AMENDMENT ENTERED

Jan 24, 2008

EXAMINER'S AMENDMENT ENTERED

EXAMINERS AMENDMENT MAILED

Dec 26, 2007

EXAMINERS AMENDMENT MAILED

EXAMINER'S AMENDMENT ENTERED

Dec 22, 2007

EXAMINER'S AMENDMENT ENTERED

SU-EXAMINER'S AMENDMENT WRITTEN

Dec 21, 2007

SU-EXAMINER'S AMENDMENT WRITTEN

NON-FINAL ACTION MAILED

Dec 18, 2007

NON-FINAL ACTION MAILED

SU - NON-FINAL ACTION - WRITTEN

Dec 17, 2007

SU - NON-FINAL ACTION - WRITTEN

ASSIGNED TO LIE

Oct 31, 2007

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 31, 2007

CORRESPONDENCE RECEIVED IN LAW OFFICE

AMENDMENT FROM APPLICANT ENTERED

Oct 31, 2007

AMENDMENT FROM APPLICANT ENTERED

PAPER RECEIVED

Sep 25, 2007

PAPER RECEIVED

NON-FINAL ACTION MAILED

Sep 05, 2007

NON-FINAL ACTION MAILED

SU - NON-FINAL ACTION - WRITTEN

Sep 04, 2007

SU - NON-FINAL ACTION - WRITTEN

STATEMENT OF USE PROCESSING COMPLETE

Aug 10, 2007

STATEMENT OF USE PROCESSING COMPLETE

PAPER RECEIVED

Jun 08, 2007

PAPER RECEIVED

USE AMENDMENT FILED

Jun 08, 2007

USE AMENDMENT FILED

ASSIGNED TO EXAMINER

Jun 05, 2007

ASSIGNED TO EXAMINER

NOA MAILED - SOU REQUIRED FROM APPLICANT

Apr 10, 2007

NOA MAILED - SOU REQUIRED FROM APPLICANT

OPPOSITION TERMINATED NO. 999999

Feb 20, 2007

OPPOSITION TERMINATED NO. 999999

PAPER RECEIVED

Nov 29, 2006

PAPER RECEIVED

OPPOSITION INSTITUTED NO. 999999

Nov 06, 2003

OPPOSITION INSTITUTED NO. 999999

PUBLISHED FOR OPPOSITION

Apr 29, 2003

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Apr 09, 2003

NOTICE OF PUBLICATION

ASSIGNED TO EXAMINER

Feb 21, 2003

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Feb 21, 2003

APPROVED FOR PUB - PRINCIPAL REGISTER

ERBITUX CETUXIMAB

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by ImClone Systems Incorporated

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Robert E. Lee, Jr.

Resources

Company